Senator Investment Group LP Iovance Biotherapeutics, Inc. Transaction History

Senator Investment Group LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $4.79 Million - $13.7 Million	-750,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $4.14 Million - $6.91 Million	250,000 Added 50.0%	750,000 $14.3 Million
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $10.2 Million - $13.3 Million	500,000 New	500,000 $12.3 Million

323

239M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.46B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

Stay updated on Senator Investment Group LP with notifications on news.